These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15545888)

  • 21. Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?
    Strauss LG; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1902-5. PubMed ID: 17938920
    [No Abstract]   [Full Text] [Related]  

  • 22. Positron emission tomography/computed tomography: use for initial staging of malignant melanoma.
    Harlan E; Davis MD; Pittelkow MR
    Int J Dermatol; 2010 Sep; 49(9):1056-8. PubMed ID: 20883270
    [No Abstract]   [Full Text] [Related]  

  • 23. FDG-PET CT for tumor imaging.
    Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
    [No Abstract]   [Full Text] [Related]  

  • 24. Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
    Hsieh TC; Lin CC; Kao CH; Wu YC; Sun SS
    Clin Nucl Med; 2016 Jan; 41(1):86-7. PubMed ID: 26402135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    Bouchelouche K; Choyke PL
    PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
    Nieweg O; Valdés Olmos R
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):602; author reply 603. PubMed ID: 17205347
    [No Abstract]   [Full Text] [Related]  

  • 27. Contribution of PET/CT for differentiation of FDG uptake in lateral pterygoid muscle in a patient with malignant melanoma.
    Yüksel M; Eziddin S; Strunk H; Biersack HJ
    Rev Esp Med Nucl; 2006; 25(2):115-6. PubMed ID: 16759619
    [No Abstract]   [Full Text] [Related]  

  • 28. FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus.
    Vogel WV; van Riel PL; Oyen WJ
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):439. PubMed ID: 17048035
    [No Abstract]   [Full Text] [Related]  

  • 29. Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
    Pawlik TM; Erasmus JJ; Truong MT; Macapinlac H; Ross MI; Gershenwald JE
    AJR Am J Roentgenol; 2006 Jul; 187(1):W117-9. PubMed ID: 16794124
    [No Abstract]   [Full Text] [Related]  

  • 30. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
    Bikhchandani J; Wood J; Richards AT; Smith RB
    Head Neck; 2014 Sep; 36(9):1313-6. PubMed ID: 23956077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography for N-and M-staging of malignant melanoma].
    Gu H; Xu W; Song X; Dai D; Zhu L; Wang J
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(17):1309-12. PubMed ID: 25142850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 33. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
    Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
    Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of positron emission tomography in the management of cutaneous melanoma.
    Friedman KP; Wahl RL
    Semin Nucl Med; 2004 Oct; 34(4):242-53. PubMed ID: 15493002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging.
    Strobel K; Skalsky J; Hany TF; Dummer R; Steinert HC
    Clin Nucl Med; 2007 Mar; 32(3):213-4. PubMed ID: 17314600
    [No Abstract]   [Full Text] [Related]  

  • 38. Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
    Bawa M; Sidhu G; Galt JR; Schuster DM; Halkar RK
    Clin Nucl Med; 2006 Jun; 31(6):347-8. PubMed ID: 16714898
    [No Abstract]   [Full Text] [Related]  

  • 39. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
    Schöder H; Larson SM; Yeung HW
    J Nucl Med; 2004 Jan; 45 Suppl 1():72S-81S. PubMed ID: 14736838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental situs inversus visualized with FDG PET/CT.
    Modi D; Fulham MJ; Mohamed A
    Clin Nucl Med; 2004 Dec; 29(12):846-7. PubMed ID: 15545903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.